About the mRNA Assay Development Summit
Curated in collaboration with key opinion leaders, the mRNA Assay Development Summit has been designed as the only industry-dedicated forum solely focused on assay development for mRNA-based drug substances and drug products, with a core focus on improving reproducibility and sensitivity of assays to enable safe and effective drugs to enter the clinic.
What 2023 Had in Store:
Delving into new potency assay methods to improve understanding of mechanism of action and fast-track mRNA-based therapeutics through the clinic with Tessera Therapeutics
Deep dive into assays developed to characterize mRNA drug products and drug substance for better investigation of quality to improve drug efficacy with Sanofi & University of Massachusetts Amherst
Improving purity of mRNA therapeutics by delving into new bioanalytical strategies for combatting the presence of dsRNA to reduce immunogenic side effects with Moderna & Senda Biosciences
Leveraging new assays for the analysis of circular mRNA and comparing with methods for linear mRNA to accurately understand the drug substance integrity and quantity with Sail Biomedicines
Increasing sensitivity by delving into methods for monitoring function and building more robust assays with Providence Therapeutics & University of Massachusetts Chan Medical School